CD137, implications in immunity and potential for therapy

Frontiers in Bioscience

Volumn 14, Issue 11, 2009, Pages 4173-4188

  Thum, Elaine ^a   Zhe, Shao ^a   Schwarz, Herbert ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

4 1BB; Antibody; Autoimmune disease; Cancer; CD137; Immunotherapy; OX40; Review; Tumor

Indexed keywords

MURINAE;

CD137 ANTIGEN; LIGAND;

HUMAN; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ANTIGENS, CD137; HUMANS; LIGANDS;

EID: 63849254074     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3521     Document Type: Article

References (107)

1. Sun Y, J H Chen, Y Fu, Immunotherapy with agonistic anti-CD137: two sides of a coin. Cell Mol. Immunol 1, 31-36(2004)
2. Mittler R S, J Foell, M McCausland, S Strahotin, L Niu, A Bapat, L B Hewes, Anti-CD137 antibodies in the treatment of autoimmune disease and cancer. Immunol. Res 29, 197-208(2004) (Pubitemid 38822409)
3. Schwarz H, Biological activities of reverse signal transduction through CD137 ligand. J. Leukoc. Biol 77, 281-286(2005) (Pubitemid 40289556)
4. Schwarz H, F J Blanco, K J von, J Valbracht, M Lotz, ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 87, 2839-2845(1996) (Pubitemid 26102233)
5. Polte T, A Jagemann, J Foell, R S Mittler, G Hansen, CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferongamma-producing CD8+ T cells. Clin. Exp. Allergy 37, 1374-1385(2007) (Pubitemid 47372292)
6. Kwon B S, S M Weissman, cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. U. S. A 86, 1963-1967(1989) (Pubitemid 19087048)
7. Schwarz H, J Tuckwell, M Lotz, A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis- factor receptor family. Gene 134, 295-298(1993)
8. Garni-Wagner B A, Z H Lee, Y J Kim, C Wilde, C Y Kang, B S Kwon, 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans. Cell Immunol 169, 91-98(1996)
9. Kwon B S, G S Kim, M B Prystowsky, D W Lancki, D E Sabath, J L Pan, S M Weissman, Isolation and initial characterization of multiple species of T-lymphocyte subset cDNA clones. Proc. Natl. Acad. Sci. U. S. A 84, 2896-2900(1987) (Pubitemid 17064745)
10. Pollok K E, Y J Kim, Z Zhou, J Hurtado, K K Kim, R T Pickard, B S Kwon, Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol 150, 771-781(1993) (Pubitemid 23133657)
11. Schwarz H, J Valbracht, J Tuckwell, K J von, M Lotz, ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85, 1043-1052(1995)
12. Melero I, J V Johnston, W W Shufford, R S Mittler, L Chen, NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell. Immunol 190, 167-172(1998) (Pubitemid 29011104)
13. Futagawa T, H Akiba, T Kodama, K Takeda, Y Hosoda, H Yagita, K Okumura, Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol 14, 275-286(2002) (Pubitemid 34213639)
14. Choi B K, J S Bae, E M Choi, W J Kang, S Sakaguchi, D S Vinay, B S Kwon, 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells. J. Leukoc. Biol 75, 785-791(2004) (Pubitemid 38580058)
15. Lindstedt M, B Johansson-Lindbom, C A Borrebaeck, Expression of CD137 (4-1BB) on human follicular dendritic cells. Scand. J. Immunol 57, 305-310(2003) (Pubitemid 36408200)
16. Pauly S, K Broll, M Wittmann, G Giegerich, H Schwarz, CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers. J. Leukoc. Biol 72, 35-42(2002)
17. von K J, H Schwarz, M Lotz, Differentiationdependent and stimulus-specific expression of ILA, the human 4-1BB-homologue, in cells of mesenchymal origin. Osteoarthritis. Cartilage 5, 394-406(1997) (Pubitemid 27522759)
18. Reali C, M Curto, V Sogos, F Scintu, S Pauly, H Schwarz, F Gremo, Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2. J. Neurosci. Res 74, 67-73(2003) (Pubitemid 37176668)
19. Curto M, C Reali, G Palmieri, F Scintu, M L Schivo, V Sogos, M A Marcialis, M G Ennas, H Schwarz, G Pozzi, F Gremo, Inhibition of cytokines expression in human microglia infected by virulent and non-virulent mycobacteria. Neurochem. Int 44, 381-392(2004) (Pubitemid 37548403)
20. Drenkard D, F M Becke, J Langstein, T Spruss, L A Kunz-Schughart, T E Tan, Y C Lim, H Schwarz, CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J 21, 456-463(2007) (Pubitemid 46213493)
21. Olofsson P S, L A Soderstrom, D Wagsater, Y Sheikine, P Ocaya, F Lang, C Rabu, L Chen, M Rudling, P Aukrust, U Hedin, G Paulsson-Berne, A Sirsjo, G K Hansson, CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 117, 1292-1301(2008) (Pubitemid 351365671)
22. Lisignoli G, S Toneguzzi, L Cattini, C Pozzi, A Facchini, Different expression pattern of cytokine receptors by human osteosarcoma cell lines. Int. J. Oncol 12, 899-903(1998) (Pubitemid 28133585)
23. Vinay D S, B S Kwon, Genes, transcripts and proteins of CD137 receptor and ligand. In: CD137 Pathway: Immunology and Diseases. Eds: Chen L P, Springer, NY (2006)
24. Schwarz H, K Arden, M Lotz, CD137, a member of the tumor necrosis factor receptor family, is located on chromosome 1p36, in a cluster of related genes, and colocalizes with several malignancies. Biochem. Biophys. Res. Commun 235, 699-703(1997) (Pubitemid 27326546)
25. Alderson M R, C A Smith, T W Tough, T vis-Smith, R J Armitage, B Falk, E Roux, E Baker, G R Sutherland, W S Din, Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol 24, 2219-2227(1994) (Pubitemid 24276559)
26. Goodwin R G, W S Din, T vis-Smith, D M Anderson, S D Gimpel, T A Sato, C R Maliszewski, C I Brannan, N G Copeland, N A Jenkins, Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol 23, 2631-2641(1993) (Pubitemid 23295149)
27. Zhou Z, S Kim, J Hurtado, Z H Lee, K K Kim, K E Pollok, B S Kwon, Characterization of human homologue of 4-1BB and its ligand. Immunol. Lett 45, 67-73(1995)
28. Palma C, M Binaschi, M Bigioni M, C A Maggi, C Goso, CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival. Int. J. Cancer 108, 390-398(2004) (Pubitemid 37549604)
29. De Benedette M A, A Shahinian, T W Mak, T H Watts, Costimulation of CD28-T lymphocytes by 4-1BB ligand. J. Immunol 158, 551-559(1997) (Pubitemid 127492629)
30. Pollok K E, Y J Kim, J Hurtado, Z Zhou, K K Kim, B S Kwon, 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur. J. Immunol 24, 367-374(1994) (Pubitemid 24041126)
31. Ju S W, S G Ju, F M Wang, Z J Gu, Y H Qiu, G H Yu, H B Ma, X G Zhang, A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL. Hybrid. Hybridomics 22, 333-338(2003)
32. Laderach D, A Wesa, A Galy, 4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12. Cell Immunol 226, 37-44(2003) (Pubitemid 38121296)
33. Kim Y J, G Li, H E Broxmeyer, 4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34+ progenitor cells. J. Hematother. Stem Cell Res 11, 895-903(2002) (Pubitemid 36139770)
34. Lee, P K, C J Chang, C M Lin, Lipopolysaccharide preferentially induces 4-1BB ligand expression on human monocyte-derived dendritic cells. Immunol. Lett 90, 215-221(2003)
35. Salih, H R, S G Kosowski, V F Haluska, G C Starling, D T Loo, F Lee, A A Aruffo, P A Trail, P A Kiener, Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells. J. Immunol 165, 2903-2910(2000) (Pubitemid 30660743)
36. De Benedette M A, N R Chu, K E Pollok, J Hurtado, W F Wade, B S Kwon, T H Watts, Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J. Exp. Med 181, 985-992(1995)
37. Starck L, C Scholz, B Dorken, P T Daniel, Costimulation by CD137/4-1BB inhibits T cell apoptosis and induces Bcl-xL and c-FLIP (short) via phosphatidylinositol 3-kinase and AKT/protein kinase B. Eur. J. Immunol 35, 1257-1266(2005) (Pubitemid 40542233)
38. Laderach D, M Movassagh, A Johnson, R S Mittler, A Galy, 4-1BB co-stimulation enhances human CD8 (+) T cell priming by augmenting the proliferation and survival of effector CD8 (+) T cells. Int. Immunol 14, 1155-1167(2002) (Pubitemid 35175223)
39. Bukczynski J, T Wen, T H Watts, Costimulation of human CD28-T cells by 4-1BB ligand. Eur. J. Immunol 33, 446-454(2003) (Pubitemid 36267610)
40. Wen T, J Bukczynski, T H Watts, 4-1BB ligandmediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J. Immunol 168, 4897-4906(2002) (Pubitemid 34495951)
41. Maus M V, A K Thomas, D G Leonard, D Allman, K Addya, K Schlienger, J L Riley, C H June, Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat. Biotechnol 20, 143-148(2002) (Pubitemid 34158029)
42. Cooper D, P Bansal-Pakala, M Croft, 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol 32, 521-529(2002) (Pubitemid 34173343)
43. Shuford W W, K Klussman, D D Tritchler, D T Loo, J Chalupny, A W Siadak, T J Brown, J Emswiler, H Raecho, C P Larsen, T C Pearson, J A Ledbetter, A Aruffo, R S Mittler, 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med 186, 47-55(1997) (Pubitemid 27304846)
44. Melero I, W W Shuford, S A Newby, A Aruffo, J A Ledbetter, K E Hellstrom, R S Mittler, L Chen, Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med 3, 682-685(1997) (Pubitemid 27264981)
45. Mittler R S, T S Bailey, K Klussman, M D Trailsmith, M K Hoffmann, Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J. Exp. Med 190, 1535-1540(1999)
46. Foell J, S Strahotin, S P O'Neil, M M McCausland, C Suwyn, M Haber, P N Chander, A S Bapat, X J Yan, N Chiorazzi, M K Hoffmann, R S Mittler, CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice. J. Clin. Invest 111, 1505-1518(2003) (Pubitemid 38063283)
47. Foell J L, B I ez-Mendiondo, O H Diez, U Holzer, P Ruck, A S Bapat, M K Hoffmann, R S Mittler, G E Dannecker, Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance. Immunology 113, 89-98(2004) (Pubitemid 39178847)
48. Seo S K, J H Choi, Y H Kim, W J Kang, H Y Park, J H Suh, B K Choi, D S Vinay, B S Kwon, 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med 10, 1088-1094(2004) (Pubitemid 39424870)
49. Choi B K, T Asai, D S Vinay, Y H Kim, B S Kwon, 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2, 3-dioxygenase-dependent mechanisms. Cytokine 34, 233-242(2006) (Pubitemid 44224104)
50. Morris G P, L Chen, Y C Kong, CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell Immunol 226, 20-29(2003) (Pubitemid 38121294)
51. Zheng G, B Wang, A Chen, The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells. J. Immunol 173, 2428-2434(2004) (Pubitemid 39063099)
52. Bertram E M, P Lau, T H Watts, Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J. Immunol 168, 3777-3785(2002) (Pubitemid 34298377)
53. Tan J T, J K Whitmire, R Ahmed, T C Pearson, C P Larsen, 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol 163, 4859-4868(1999) (Pubitemid 29501250)
54. Sun Y, X Lin, H M Chen, Q Wu, S K Subudhi, L Chen, Y X Fu, Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J. Immunol 168, 1457-1465(2002) (Pubitemid 34094519)
55. Mellor A L, B Baban, P Chandler, B Marshall, K Jhaver, A Hansen, P A Koni, M Iwashima, D H Munn, Cutting edge: induced indole-amine 2, 3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol 171, 1652-1655(2003) (Pubitemid 36966447)
56. Zhang B, C H Maris, J Foell, J Whitmire, L Niu, J Song, B S Kwon, A T Vella, R Ahmed, J Jacob, R S Mittler, Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J. Clin. Invest 117, 3029-3041(2007) (Pubitemid 47529632)
57. Eissner G, W Kolch, P Scheurich, Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev 15, 353-366(2004) (Pubitemid 39140699)
58. Wilkinson D G Eph receptors and ephrins: regulators of guidance and assembly. Int. Rev. Cytol 196, 177-244(2000) (Pubitemid 30130841)
59. Orabona C, U Grohmann, M L Belladonna, F Fallarino, C Vacca, R Bianchi, S Bozza, C Volpi, B L Salomon, M C Fioretti, L Romani, P Puccetti, CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol 5, 1134-1142(2004) (Pubitemid 39549627)
60. Langstein J, F M Becke, L Sollner, G Krause, G Brockhoff, M Kreutz, R Andreesen, H Schwarz, Comparative analysis of CD137 and LPS effects on monocyte activation, survival, and proliferation. Biochem. Biophys. Res. Commun 273, 117-122(2000) (Pubitemid 30426872)
61. Langstein J, J Michel, J Fritsche, M Kreutz, R Andreesen, H Schwarz, CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol 160, 2488-2494(1998) (Pubitemid 28119935)
62. Langstein J, J Michel, H Schwarz, CD137 induces proliferation and endomitosis in monocytes. Blood 94, 3161-3168(1999) (Pubitemid 29512724)
63. Langstein J, H Schwarz, Identification of CD137 as a potent monocyte survival factor. J. Leukoc. Biol 65, 829-833(1999) (Pubitemid 29279533)
64. Kang Y J, S O Kim, S Shimada, M Otsuka, A Seit-Nebi, B S Kwon, T H Watts, J Han, Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat. Immunol 8, 601-609(2007) (Pubitemid 46785124)
65. Lippert U, K Zachmann, D M Ferrari, H Schwarz, E Brunner, A H Latif, C Neumann, A Soruri, CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Eur. J. Immunol 38, 1024-1032(2008)
66. Michel J, S Pauly, J Langstein, P H Krammer, H Schwarz, CD137-induced apoptosis is independent of CD95. Immunology 98, 42-46(1999) (Pubitemid 29425907)
67. Sollner L, D O K Shaqireen, J T Wu, H Schwarz, Signal transduction mechanisms of CD137 ligand in human monocytes. Cell Signal 19, 1899-1908(2007) (Pubitemid 47082541)
68. Setareh M, H Schwarz, M Lotz, A mRNA variant encoding a soluble form of 4-1BB, a member of the murine NGF/TNF receptor family. Gene 164, 311-315(1995)
69. Michel J, J Langstein, F Hofstadter, H Schwarz, A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur. J. Immunol 28, 290-295(1998) (Pubitemid 28048299)
70. Michel J, H Schwarz, Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes. Cytokine 12, 742-746(2000) (Pubitemid 30453509)
71. Hurtado J C, S H Kim, K E Pollok, Z H Lee, B S Kwon, (1995) Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J. Immunol 155, 3360-3367
72. Furtner M, R H Straub, S Kruger, H Schwarz, Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia. Leukemia 19, 883-885(2005) (Pubitemid 40663117)
73. Sharief M K Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis. Eur. J. Neurol 9, 49-54(2002)
74. Jung H W, S W Choi, J I Choi, B S Kwon, Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis. Exp. Mol. Med 36, 13-22(2004) (Pubitemid 38379632)
75. Liu G Z, A C Gomes, P Putheti, V Karrenbauer, K Kostulas, R Press, J Hillert, P Hjelmstrom, X G Gao, Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis. Scand. J. Immunol 64, 412-419(2006) (Pubitemid 44408797)
76. Zhang G B, Q M Dong, J Q Hou, Y Ge, S G Ju, B F Lu, X G Zhang, Characterization and application of three novel monoclonal antibodies against human 4-1BB: distinct epitopes of human 4-1BB on lung tumor cells and immune cells. Tissue Antigens 70, 470-479(2007) (Pubitemid 350075794)
77. Broll K, G Richter, S Pauly, F Hofstaedter, H Schwarz, CD137 expression in tumor vessel walls. High correlation with malignant tumors. Am. J. Clin. Pathol 115, 543-549(2001) (Pubitemid 32275946)
78. Mantovani A, P Allavena, A Sica, Tumourassociated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur. J. Cancer 40, 1660-1667(2004) (Pubitemid 38902900)
79. Salih H R, H M Schmetzer, C Burke, G C Starling, R Dunn, R Pelka-Fleischer, V Nuessler, P A Kiener, Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies. J. Immunol 167, 4059-4066(2001) (Pubitemid 32910853)
80. Hentschel N, M Krusch, P A Kiener, H J Kolb, H R Salih, H M Schmetzer, Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma. Eur. J. Haematol 77, 91-101(2006)
81. Seo S K, H Y Park, J H Choi, W Y Kim, Y H Kim, H W Jung, B Kwon, H W Lee, B S Kwon, Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J. Immunol 171, 576-583(2003) (Pubitemid 36871364)
82. Vinay D S, J D Kim, T Asai, B K Choi, B S Kwon, Absence of 4 1BB gene function exacerbates lacrimal gland inflammation in autoimmune-prone MRL-Faslpr mice. Invest Ophthalmol. Vis. Sci 48, 4608-4615(2007) (Pubitemid 351260978)
83. Lee S W, A T Vella, B S Kwon, M Croft, Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J. Immunol 174, 6803-6808(2005) (Pubitemid 40705643)
84. Vinay D S, J H Choi, J D Kim, B K Choi, B S Kwon, Role of endogenous 4-1BB in the development of systemic lupus erythematosus. Immunology 122, 394-400(2007) (Pubitemid 47556476)
85. Cannons J L, G Chamberlain, J Howson, L J Smink, J A Todd, L B Peterson, L S Wicker, T H Watts, Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes. J. Autoimmun 25, 13-20(2005) (Pubitemid 41008662)
86. Heinisch I V, C Bizer, W Volgger, H U Simon, Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders. J. Allergy Clin. Immunol 108, 21-28(2001) (Pubitemid 32662228)
87. Kim D H, W S Chang, Y S Lee, K A Lee, Y K Kim, B S Kwon, C Y Kang, 4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligandinduced airway hyperresponsiveness and inflammation. J. Immunol 180, 2062-2068(2008)
88. Lynch D H, The promise of 4-1BB (CD137) - mediated immunomodulation and the immunotherapy of cancer. Immunol. Rev 222, 277-286(2008) (Pubitemid 351430383)
89. Son J H, U H Lee, J J Lee, B Kwon, B S Kwon, J W Park, Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library. J. ImmunolMethods 286, 187-201(2004) (Pubitemid 38490407)
90. Hong H J, J W Lee, S S Park, Y J Kang, S Y Chang, K M Kim, J O Kim, K K Murthy, J S Payne, S K Yoon, M J Park, I C Kim, J G Kim, C Y Kang, A humanized anti-4-1BB monoclonal antibody suppresses antigeninduced humoral immune response in nonhuman primates. J. Immunother 23, 613-621(2000)
91. McNamara J O, D Kolonias, F Pastor, R S Mittler, L Chen, P H Giangrande, B Sullenger, E Gilboa, Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. J. Clin. Invest 118, 376-386(2008)
92. Lee S J, L Myers, G Muralimohan, J Dai, Y Qiao, Z Li, R S Mittler, A T Vella, 4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function. J. Immunol 173, 3002-3012(2004) (Pubitemid 39142005)
93. Cuadros C, A L Dominguez, P L Lollini, M Croft, R S Mittler, P Borgstrom, J Lustgarten, Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice. Int. J. Cancer 116, 934-943(2005) (Pubitemid 41209201)
94. Lee S J, R J Rossi, S K Lee, M Croft, B S Kwon, R S Mittler, A T Vella, CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent. J. Immunol 179, 2203-2214(2007)
95. Teng M W, J A Westwood, P K Darcy, J Sharkey, M Tsuji, R W Franck, S A Porcelli, G S Besra, K Takeda, H Yagita, M H Kershaw, M J Smyth, Combined natural killer T-cell based immunotherapy eradicates established tumors in mice. Cancer Res 67, 7495-7504(2007) (Pubitemid 47206579)
96. Halstead E S, Y M Mueller, J D Altman, P D Katsikis, In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat. Immunol 3, 536-541(2002) (Pubitemid 34662305)
97. Munks M W, D V Mourich, R S Mittler, A D Weinberg, A B Hill, 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. Immunology 112, 559-566(2004) (Pubitemid 39061480)
98. Harrison J M, E M Bertram, D B Boyle, B E Coupar, C Ranasinghe, I A Ramshaw, 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine. Vaccine 24, 6867-6874(2006) (Pubitemid 46107184)
99. Wang C, T Wen, J P Routy, N F Bernard, R P Sekaly, T H Watts, 4-1BBL induces TNF receptorassociated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulationdependent rescue of functionally impaired HIV-specific CD8 T cells. J. Immunol 179, 8252-8263(2007)
100. Al-Shamkhani A, CD137: costimulator turns suppressor? Immunology 113, 23-25(2004) (Pubitemid 39178840)
101. Myers L M, A T Vella, Interfacing T-cell effector and regulatory function through CD137 (4-1BB) costimulation. Trends Immunol 26, 440-446(2005) (Pubitemid 41008081)
102. Blazar B R, B S Kwon, A Panoskaltsis-Mortari, K B Kwak, J J Peschon, P A Taylor, Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graftversus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J. Immunol 166, 3174-3183(2001) (Pubitemid 33117315)
103. Kim J, W S Choi, S La, J H Suh, B S Kim, H R Cho, B S Kwon, B Kwon, Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells. Blood 105, 2206-2213(2005) (Pubitemid 40731814)
104. Sytwu H K, W D Lin, S R Roffler, J T Hung, H S Sung, C H Wang, T L Cheng, S C Tsou, S C Hsi, K L Shen, Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic nonobese diabetic (NOD) model. J. Autoimmun 21, 247-254(2003) (Pubitemid 37410112)
105. Chan F K, H J Chun, L Zheng, R M Siegel, K L Bui, M J Lenardo, A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351-2354(2000) (Pubitemid 30448156)
106. Roesler J, J M Izquierdo, M Ryser, A Rosen-Wolff, M Gahr, J Valcarcel, M J Lenardo, L Zheng, Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95{Delta}TM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele. Blood 106, 1652-1659(2005) (Pubitemid 41208578)
107. Redmond W L, M J Gough, B Charbonneau, T L Ratliff, A D Weinberg, Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist. J. Immunol 179, 7244-7253(2007)